Vimarsana
Biggest News Aggregation in the World

Davidj Bearss News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Davidj Bearss. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Davidj Bearss Today - Breaking & Trending Today

Halia Therapeutics Continued Support to Utah's Industry Community Recognized by First Place at the Utah Business Innovation Awards - Vimarsana News

Halia Therapeutics Continued Support to Utah's Industry Community Recognized by First Place at the Utah Business Innovation Awards

/PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by...

Halia Therapeutics Continued Support to Utah's Industry Community Recognized by First Place at the Utah Business Innovation Awards - Vimarsana News

Halia Therapeutics Continued Support to Utah's Industry Community Recognized by First Place at the Utah Business Innovation Awards

Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by chronic inflammation and neurodegeneration, today announced that the company has been awarded first place in...

Biolexis debuts subsidiary using AI to develop diabetes, weight loss drugs - Vimarsana News

Biolexis debuts subsidiary using AI to develop diabetes, weight loss drugs

Metabolexis will use AI capabilities to focus on GLP-1 weight loss and type 2 diabetic drug discoveries.

Halia Therapeutics to Present at the 17th Annual PAINWeek Conference - Vimarsana News

Halia Therapeutics to Present at the 17th Annual PAINWeek Conference

/PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing innovative medicines to treat a broad range of diseases driven by...

Halia Therapeutics Announces Completion of Enrollment for Phase I Clinical Trial of HT-6184 for Chronic Inflammation - Vimarsana News

Halia Therapeutics Announces Completion of Enrollment for Phase I Clinical Trial of HT-6184 for Chronic Inflammation

-     Halia expects to release data from the Phase I trial in Q4 2023SALT LAKE CITY, Aug. 7, 2023 /PRNewswire/ -- Halia Therapeutics, a clinical-s...